Fish protein hydrolysate elevates plasma bile acids and reduces visceral adipose tissue mass in rats

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1791, Issue 4, 2009, Pages 254-262

  Liaset, Bjørn ^a   Madsen, Lise ^a,b   Hao, Qin ^b   Criales, Gabriel ^a   Mellgren, Gunnar ^c,d   Marschall, Hanns Ulrich ^e   Hallenborg, Philip ^b   Espe, Marit ^a   Frøyland, Livar ^a   Kristiansen, Karsten ^b,f  

^a INSTITUTE OF MARINE RESEARCH   (Norway)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c UNIVERSITY OF BERGEN   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Adipose tissue; Bile acid; Energy metabolism; Fish protein hydrolysate; Obesity; Taurine

Indexed keywords

BILE ACID; FISH PROTEIN; PROTEIN HYDROLYSATE;

AMINO ACID COMPOSITION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE ACID BLOOD LEVEL; BILE ACID SYNTHESIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENERGY METABOLISM; INTRAABDOMINAL FAT; LIPID STORAGE; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN INTAKE; RAT;

ANIMALS; BILE ACIDS AND SALTS; DIETARY PROTEINS; ENERGY METABOLISM; FISHES; GLYCINE; INTRA-ABDOMINAL FAT; LIPIDS; LIVER; MALE; MITOCHONDRIA, LIVER; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PROTEIN HYDROLYSATES; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TAURINE; TRIGLYCERIDES;

POLLACHIUS VIRENS; RATTUS;

EID: 62249085383     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2009.01.016     Document Type: Article

References (62)

1. Parks D.J., Blanchard S.G., Bledsoe R.K., Chandra G., Consler T.G., Kliewer S.A., Stimmel J.B., Willson T.M., Zavacki A.M., Moore D.D., and Lehmann J.M. Bile acids: natural ligands for an orphan nuclear receptor. Science 284 (1999) 1365-1368
2. Makishima M., Okamoto A.Y., Repa J.J., Tu H., Learned R.M., Luk A., Hull M.V., Lustig K.D., Mangelsdorf D.J., and Shan B. Identification of a nuclear receptor for bile acids. Science 284 (1999) 1362-1365
3. Gerloff T., Geier A., Roots I., Meier P.J., and Gartung C. Functional analysis of the rat bile salt export pump gene promoter-regulation by bile acids, drugs and endogenous compounds. Eur. J. Biochem. 269 (2002) 3495-3503
4. Stieger B., Meier Y., and Meier P.J. The bile salt export pump. Pflug. Arch. Eur. J. Physiol. 453 (2007) 611-620
5. Shonsey E.M., Sfakianos M., Johnson M., He D., Falany C.N., Falany J., Merkler D.J., and Barnes S. Bile acid coenzyme A: amino acid N-acyltransferase in the amino acid conjugation of bile acids. Meth. Enzymol. 400 (2005) 374-394
6. Vessey D.A., Whitney J., and Gollan J.L. The role of conjugation reactions in enhancing biliary-secretion of bile-acids. Biochem. J. 214 (1983) 923-927
7. Gerloff T., Meier P.J., and Stieger B. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. Liver 18 (1998) 306-312
8. Stieger B., Fattinger K., Madon J., Kullak-Ublick G.A., and Meier P.J. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (BSEP) of rat liver. Gastroenterology 118 (2000) 422-430
9. Yokogoshi H., Mochizuki H., Nanami K., Hida Y., Miyachi F., and Oda H. Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high-cholesterol diet. J. Nutr. 129 (1999) 1705-1712
10. Yamanaka Y., Tsuji K., and Ichikawa T. Stimulation of chenodeoxycholic acid excretion in hypercholesterolemic mice by dietary taurine. J. Nutr. Sci. Vitaminol. 32 (1986) 287-296
11. Sugiyama K., Ohishi A., Ohnuma Y., and Muramatsu K. Comparison between the plasma cholesterol-lowering effects of glycine and taurine in rats fed on high cholesterol diets. Agricult. Biol. Chem. 53 (1989) 1647-1652
12. Belinsky M.G., Bain L.J., Balsara B.B., Testa J.R., and Kruh G.D. Characterization of MOAT-C and MOAT-D, new members of the MRP/cMOAT subfamily of transporter proteins. J. Natl. Cancer Inst. 90 (1998) 1735-1741
13. Mennone A., Soroka C.J., Cai S.Y., Harry K., Adachi M., Hagey L., Schuetz J.D., and Boyer J.L. Mrp4-/- mice have an impaired cytoprotective response in obstructive cholestasis. Hepatology 43 (2006) 1013-1021
14. Schuetz E.G., Strom S., Yasuda K., Lecureur V., Assem M., Brimer C., Lamba J., Kim R.B., Ramachandran V., Komoroski B.J., Venkataramanan R., Cai H.B., Sinal C.J., Gonzalez F.J., and Schuetz J.D. Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome p450. J. Biol. Chem. 276 (2001) 39411-39418
15. Denk G.U., Soroka C.J., Takeyama Y., Chen W.-S., Schuetz J.D., and Boyer J.L. Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat. J. Hepatol. 40 (2004) 585-591
16. Zelcer N., Wetering K.v.d., Waart R.d., Scheffer G.L., Marschall H.-U., Wielinga P.R., Kuil A., Kunne C., Smith A., Valk M.v.d., Wijnholds J., Elferink R.O., and Borst P. Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides. J. Hepatol. 44 (2006) 768-775
17. Rius M., Hummel-Eisenbeiss J., Hofmann A.F., and Keppler D. Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione. Am. J. Physiol. Gastrointest. Liver Physiol. 290 (2006) G640-649
18. Maruyama T., Miyamoto Y., Nakamura T., Tamai Y., Okada H., Sugiyama E., Itadani H., and Tanaka K. Identification of membrane-type receptor for bile acids (M-BAR). Biochem. Biophys. Res. Comm. 298 (2002) 714-719
19. Kawamata Y., Fujii R., Hosoya M., Harada M., Yoshida H., Miwa M., Fukusumi S., Habata Y., Itoh T., Shintani Y., Hinuma S., Fujisawa Y., and Fujino M. A G protein-coupled receptor responsive to bile acids. J. Biol. Chem. 278 (2003) 9435-9440
20. Maruyama T., Tanaka K., Suzuki J., Miyoshi H., Harada N., Nakamura T., Miyamoto Y., Kanatani A., and Tamai Y. Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice. J. Endocrinol. 191 (2006) 197-205
21. Ikemoto S., Takahashi M., Tsunoda N., Maruyama K., Itakura H., Kawanaka K., Tabata I., Higuchi M., Tange T., Yamamo T.T., and Ezaki O. Cholate inhibits high-fat diet-induced hyperglycemia and obesity with acyl-CoA synthetase mRNA decrease. Am. J. Physiol. Endocrinol. Metab. 36 (1997) E37-E45
22. Watanabe M., Houten S.M., Mataki C., Christoffolete M.A., Kim B.W., Sato H., Messaddeq N., Harney J.W., Ezaki O., Kodama T., Schoonjans K., Bianco A.C., and Auwerx J. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439 (2006) 484-489
23. Houten S.M., Watanabe M., and Auwerx J. Endocrine functions of bile acids. Embo J. 25 (2006) 1419-1425
24. Cariou B., and Staels B. FXR: a promising target for the metabolic syndrome?. Trends Pharmacol. Sci. 28 (2007) 236-243
25. Liaset B., and Espe M. Nutritional composition of soluble and insoluble fractions obtained by enzymatic hydrolysis of fish-raw materials. Proc. Biochem. 43 (2008) 42-48
26. Cohen S.A., and Strydom D.J. Amino-acid analysis utilizing phenylisothiocyanate derivatives. Anal. Biochem. 174 (1988) 1-16
27. Nedergaard J., and Cannon B. Overview-preparation and properties of mitochondria from different sources. Meth. Enzymol. 55 (1979) 3-28
28. Madsen L., Rustan A.C., Vaagenes H., Berge K., Dyroy E., and Berge R.K. Eicosapentaenoic and docosahexaenoic acid affect mitochondrial and peroxisomal fatty acid oxidation in relation to substrate preference. Lipids 34 (1999) 951-963
29. ). Proc. Biochem. 38 (2003) 1747-1759
30. Suckling K.E., Benson G.M., Bond B., Gee A., Glen A., Haynes C., and Jackson B. Cholesterol lowering and bile acid excretion in the hamster with cholestyramine treatment. Atherosclerosis 89 (1991) 183-190
31. Marschall H.-U., Wagner M., Bodin K., Zollner G., Fickert P., Gumhold J., Silbert D., Fuchsbichler A., Sjovall J., and Trauner M. Fxr-/- mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids. J. Lipid Res. 47 (2006) 582-592
32. Galman C., Arvidsson I., Angelin B., and Rudling M. Monitoring hepatic cholesterol 7 alpha-hydroxylase activity by assay of the stable bile acid intermediate 7 alpha-hydroxy-4-cholesten-3-one in peripheral blood. J. Lipid Res. 44 (2003) 859-865
33. Galman C., Angelin B., and Rudling M. Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis. Gastroenterology 129 (2005) 1445-1453
34. Madsen L., Petersen R.K., Sorensen M.B., Jorgensen C., Hallenborg P., Pridal L., Fleckner J., Amri E.Z., Krieg P., Flirstenberger G., Berge R.K., and Kristiansen K. Adipocyte differentiation of 3T3-L1 preadipocytes is dependent on lipoxygenase activity during the initial stages of the differentiation process. Biochem. J. 375 (2003) 539-549
35. van Aubel R.A.M.H., Smeets P.H.E., Peters J.G.P., Bindels R.J.M., and Russel F.G.M. The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP. J. Am. Soc. Nephrol. 13 (2002) 595-603
36. Hansen J.B., Petersen R.K., Larsen B.M., Bartkova J., Alsner J., and Kristiansen K. Activation of peroxisome proliferator-activated receptor γ bypasses the function of the retinoblastoma protein in adipocyte differentiation. J. Biol. Chem. 274 (1999) 2386-2393
37. Axelson M., Bjorkhem I., Reihner E., and Einarsson K. The plasma-level of 7-alpha-hydroxy-4-cholesten-3-one reflects the activity of hepatic cholesterol 7-alpha-hydroxylase in man. FEBS Letters 284 (1991) 216-218
38. Sauter G., Berr F., Beuers U., Fischer S., and Paumgartner G. Serum concentrations of 7 alpha-hydroxy-4-cholesten-3-one reflect bile acid synthesis in humans. Hepatology 24 (1996) 123-126
39. Kast H.R., Nguyen C.M., Sinal C.J., Jones S.A., Laffitte B.A., Reue K., Gonzalez F.J., Willson T.M., and Edwards P.A. Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids. Mol. Endocrinol. 15 (2001) 1720-1728
40. Watanabe M., Houten S.M., Wang L., Moschetta A., Mangelsdorf D.J., Heyman R.A., Moore D.D., and Auwerx J. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J. Clin. Invest. 113 (2004) 1408-1418
41. Angelin B., Einarsson K., Hellström K., and Leijd B. Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinemia. J. Lipid Res. 19 (1978) 1017-1024
42. Bateson M.C., MacLean D., Evans J.R., and Bouchier I.A.D. Chenodeoxycholic acid therapy for hypertriglyceridaemia in men. Br. J. Clin. Pharmacol. 5 (1978) 249-254
43. Hirokane H., Nakahara M., Tachibana S., Shimizu M., and Sato R. Bile acid reduces the secretion of very low density lipoprotein by repressing microsomal triglyceride transfer protein gene expression mediated by hepatocyte nuclear factor-4. J. Biol. Chem. 279 (2004) 45685-45692
44. Lin Y.G., Havinga R., Verkade H.J., Moshage H., Slooff M.J.H., Vonk R.J., and Kuipers F. Bile acids suppress the secretion of very-low-density lipoprotein by human hepatocytes in primary culture. Hepatology 23 (1996) 218-228
45. Lin Y.G., Havinga R., Schippers I.J., Verkade H.J., Vonk R.J., and Kuipers F. Characterization of the inhibitory effects of bile acids on very-low-density lipoprotein secretion by rat hepatocytes in primary culture. Biochem. J. 316 (1996) 531-538
46. Cortes V., Amigo L., Donoso K., Valencia I., Quinones V., Zanlungo S., Brandan E., and Rigotti A. Adenovirus-mediated hepatic syndecan-1 overexpression induces hepatocyte proliferation and hyperlipidaemia in mice. Liver Internat. 27 (2007) 569-581
47. Wu Z., Puigserver P., Andersson U., Zhang C., Adelmant G., Mootha V., Troy A., Cinti S., Lowell B., Scarpulla R.C., and Spiegelman B.M. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98 (1999) 115-124
48. Lin J., Handschin C., and Spiegelman B.M. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 1 (2005) 361-370
49. Iwami K., Sakakibara K., and Ibuki F. Involvement of post-digestion hydrophobic peptides in plasma cholesterol-lowering effect of dietary plant-proteins. Agricult. Biol. Chem. 50 (1986) 1217-1222
50. Gatchalian-Yee M., Arimura Y., Ochiai E., Yamada K., and Sugano M. Soybean protein lowers serum cholesterol levels in hamsters: effect of debittered undigested fraction. Nutrition 13 (1997) 633-639
51. Sugano M., Goto S., Yamada Y., Yoshida K., Hashimoto Y., Matsuo T., and Kimoto M. The hypocholesterolemic action of the undigested fraction of soybean protein in rats. Atherosclerosis 72 (1988) 115-122
52. Wang M.F., Yamamoto S., Chung H.-M., Chung S.-Y., Miyatani S., Mori M., Okita T., and Sugano M. Antihypocholesterolemic effect of undigested fraction of soybean protein in young female volunteers. J. Nutr. Sci. Vitaminol. 41 (1995) 187-195
53. Lee J., Azzaroli F., Wang L., Soroka C.J., Gigliozzi A., Setchell K.D.R., Kramer W., and Boyer J.L. Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat. Gastroenterology 121 (2001) 1473-1484
54. Sinal C.J., Tohkin M., Miyata M., Ward J.M., Lambert G., and Gonzalez F.J. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102 (2000) 731-744
55. Wagner M., Fickert P., Zollner G., Fuchsbichler A., Silbert D., Tsybrovskyy O., Zatloukal K., Guo G.L., Schuetz J.D., Gonzalez F.J., Marschall H.U., Denk H., and Trauner M. Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. Gastroenterology 125 (2003) 825-838
56. Huls M., van den Heuvel J.J., Dijkman H.B., Russel F.G., and Masereeuw R. ABC transporter expression profiling after ischemic reperfusion injury in mouse kidney. Kidney Internat. 69 (2006) 2186-2193
57. Heemskerk S., van Koppen A., van den Broek L., Poelen G.J.M., Wouterse A.C., Dijkman H.B.P.M., Russel F.G.M., and Masereeuw R. Nitric oxide differentially regulates renal ATP-binding cassette transporters during endotoxemia. Pflüg. Arch. Eur. J. Physiol. 454 (2007) 321-334
58. Carulli N., Ponz de Leon M., Podda M., Zuin M., Strata A., Frigerio G., and Digrisolo A. Chenodeoxycholic acid and ursodeoxycholic acid effects in endogenous hypertriglyceridemias. a controlled double-blind trial. J. Clin. Pharmacol. 21 (1981) 436-442
59. Conley D.R., Coyne M.J., Bonorris G.G., Chung A., and Schoenfield L.J. Bile-acid stimulation of colonic adenylate-cyclase and secretion in rabbit. Am. J. Digest. Dis. 21 (1976) 453-458
60. Potter G.D., Sellin J.H., and Burlingame S.M. Bile-acid stimulation of cyclic-Amp and ion-transport in developing rabbit colon. J. Ped. Gastroenterol. Nutr. 13 (1991) 335-341
61. Hansen J.B., and Kristiansen K. Regulatory circuits controlling white versus brown adipocyte differentiation. Biochem. J. 398 (2006) 153-168
62. Kissebah A.H., and Krakower G.R. Regional adiposity and morbidity. Physiol. Rev. 74 (1994) 761-811